Malaysia: +603 2779 0098
Fatty liver disease is considered one of the major challenges in contemporary clinical practice with the prevalence being as high as 25% of the world’s population. Rick Grobbee focuses here on the “Global Research Initiative for Patient Screening on NASH” to help with the lack of knowledge around diagnosing and treating patients.
Only products with same currency can be added to the basket. Clear the basket or finish the order, before adding products with another currency to the basket.
